Product Images Oxybutynin Chloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Oxybutynin Chloride NDC 43063-931 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

43063931 label - 43063931

43063931 label - 43063931

This is a warning label for a medication called Oxybutynin Chloride USP, with a strength of 5 mg per tablet and comes in a pack of 30 tablets. The medication may cause drowsiness and should be taken without consuming alcohol. The lot number is G19E59 with an expiry date of 11/2020. There is a caution against overdosage, and the package insert should be followed for usage and storage information. The tablets are blue, round, and scored, and the manufacturer is PD-Rx Pharmaceuticals Incorporated, located in Oklahoma City. Call a doctor for medical advice on any side effects, and there are FDA contact details provided. Lastly, it indicates the dosage instructions in both English and Spanish to take the tablets several times a day.*

Structural Formula - figure 1 structure

Structural Formula - figure 1 structure

Table 1 - figure 2 table1

Table 1 - figure 2 table1

This is a comparison between two different forms of Butynin, R-Oybutynin, and S-Ouybutynin. The data shows the values for parameters including G (ng/mL), Toa (1), AUC (ng=h/mL), and UGy (ngehiml). However, without additional context, it is not clear what these parameters represent.*

Figure 1 - figure 3 figure1

Figure 1 - figure 3 figure1

Table 2 - figure 4 table2

Table 2 - figure 4 table2

Figure 2 - figure 5 figure2

Figure 2 - figure 5 figure2

Table 3 - figure 6 table3

Table 3 - figure 6 table3

Oxybutynin Chloride is a medication that can cause various adverse events in the body system. It can lead to urinary tract infections, insomnia, nervousness, dizziness, somnolence, headache, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention. The percentage of occurrence is provided for each adverse event.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.